FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes

28 August 2021 (17:46 - 17:50)
Organised by:
Congress Presentation Part of: Hot Line - FIGARO-DKD / FIDELITY Analysis Aldosterone Antagonists ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by